Tonga Healthcare Daily: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tonga Healthcare Daily.

Press releases published on July 31, 2026

11 hours ago

Vistagen Appoints Douglas J. Williamson to its Board of Directors

Indeterminate GlobeNewswire

11 hours ago

NOMAD Power Solutions Announces Options Trading Begins on Cboe Options Exchange

Indeterminate GlobeNewswire

11 hours ago

Achieve Life Sciences Announced Granting of New Hire Inducement Awards

Indeterminate GlobeNewswire

11 hours ago

Cerenome Launches as an Integrated CNS Oncology Company

Indeterminate GlobeNewswire

11 hours ago

SciSparc: Subsidiary NeuroThera Labs' Quantum Platform Demonstrates Complete End-to-End Hybrid Quantum-Classical Workflow for Clinical Data Analytics

Indeterminate GlobeNewswire

11 hours ago

IRADIMED CORPORATION Reports Second Quarter 2026 Financial Results

Indeterminate GlobeNewswire

11 hours ago

Moleculin’s MIRACLE R/R AML Trial Reports Positive Interim Data with 37% Blinded CRc in Venetoclax-Failed Patients

Indeterminate GlobeNewswire

11 hours ago

Jushi Holdings Inc. Completes Redomicile from British Columbia to Nevada

Indeterminate GlobeNewswire

11 hours ago

Elutia to Report Second Quarter 2026 Financial Results on Thursday, August 13, 2026

Indeterminate GlobeNewswire

11 hours ago

Picard Medical / SynCardia Presents Emperor Total Artificial Heart Architecture for the First Time at IEEE EMBC 2026

Indeterminate GlobeNewswire

11 hours ago

J-Star Holding Co., Ltd Regains Compliance with Nasdaq Minimum Bid Price Requirement

Indeterminate GlobeNewswire

12 hours ago

Medicus Pharma Receives UAE Department of Health (DOH) Authorization to proceed with Novel Prospective Genomics Guided Precision Medicine Study Evaluating Teverelix® in Women with Endometriosis

Indeterminate GlobeNewswire

12 hours ago

Ocugen to Participate in Upcoming August Investor Conferences

Indeterminate GlobeNewswire

12 hours ago

Radiopharm Theranostics Reports Business Update

Indeterminate GlobeNewswire

12 hours ago

INmune Bio Inc. to Report Second Quarter 2026 Financial Results and Provide Corporate Update on Thursday, August 6th

Indeterminate GlobeNewswire

12 hours ago

Tenax Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Indeterminate GlobeNewswire

12 hours ago

Werewolf Therapeutics Reports Second Quarter 2026 Financial Results and Recent Corporate Updates

Indeterminate GlobeNewswire

12 hours ago

INmune Bio Receives R&D Rebates of Approximately $4.6 Million

Indeterminate GlobeNewswire

12 hours ago

Regeneron Awards $150,000 to Winners of the 2026 Regeneron Prize for Creative Innovation

Indeterminate GlobeNewswire

12 hours ago

Tiziana Reports Reduction in Brain Inflammation in Third Multiple System Atrophy Patient Treated with Intranasal Foralumab

Indeterminate GlobeNewswire